Evidence map›Paper›PMID 12388766›Full record

ArticleMolecular biology of the cell2002

A novel conserved RNA-binding domain protein, RBD-1, is essential for ribosome biogenesis.

Petra Björk, Göran Baurén, ShaoBo Jin, Yong-Guang Tong, Thomas R Bürglin, Ulf Hellman, Lars Wieslander

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Petra BjörkDepartment of Molecular Biology and Functional Genomics, Stockholm University, SE-106 91 Stockholm, Sweden.
Göran Baurén
ShaoBo Jin
Yong-Guang Tong
Thomas R Bürglin
Ulf Hellman
Lars Wieslander
Stockholm University · SEKarolinska Institutet · SELudwig Cancer Research · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synthesis of the ribosomal subunits from pre-rRNA requires a large number of trans-acting proteins and small nucleolar ribonucleoprotein particles to execute base modifications, RNA cleavages, and structural rearrangements. We have characterized a novel protein, RNA-binding domain-1 (RBD-1), that is involved in ribosome biogenesis. This protein contains six consensus RNA-binding domains and is conserved as to sequence, domain organization, and cellular location from yeast to human. RBD-1 is essential in Caenorhabditis elegans. In the dipteran Chironomus tentans, RBD-1 (Ct-RBD-1) binds pre-rRNA in vitro and anti-Ct-RBD-1 antibodies repress pre-rRNA processing in vivo. Ct-RBD-1 is mainly located in the nucleolus in an RNA polymerase I transcription-dependent manner, but it is also present in discrete foci in the interchromatin and in the cytoplasm. In cytoplasmic extracts, 20-30% of Ct-RBD-1 is associated with ribosomes and, preferentially, with the 40S ribosomal subunit. Our data suggest that RBD-1 plays a role in structurally coordinating pre-rRNA during ribosome biogenesis and that this function is conserved in all eukaryotes.

Indexed as

AnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsCell NucleolusChironomidaeConsensus SequenceFungal ProteinsHeLa CellsHumansInsect ProteinsMitosisNuclear ProteinsProtein Structure, TertiaryRibonucleoproteinsRibosomesRNA-Binding ProteinsCaenorhabditis elegans ProteinsFungal ProteinsInsect ProteinsNuclear ProteinsRBD-1 protein, C elegansRibonucleoproteinsRNA-Binding ProteinsRNA Polymerase IRNA, Ribosomal

Identifiers

PMID12388766
PMCPMC129975
OpenAlexW2125793286

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.